Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Molina Healthcare Inc ha un obiettivo di prezzo di consenso pari a $310.7, stabilito in base alle ultime valutazioni degli analisti di 24. Le ultime 3 valutazioni degli analisti sono state rilasciate da Cantor Fitzgerald, Wells Fargo y JP Morgan il agosto 26, 2025, agosto 15, 2025 y julio 29, 2025. Con un obiettivo di prezzo medio di $197.33 tra le Cantor Fitzgerald, Wells Fargo y JP Morgan, c'è un implicito 13.36% upside per Molina Healthcare Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Cantor Fitzgerald
Wells Fargo
JP Morgan
UBS
Truist Securities
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Molina Healthcare
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/26/2025 | 20.63% | Cantor Fitzgerald | $210 → $210 | Reiterates | Neutral → Neutral | |||
08/15/2025 | 13.74% | Wells Fargo | $216 → $198 | Maintains | Overweight | |||
07/29/2025 | 5.7% | JP Morgan | $272 → $184 | Maintains | Neutral | |||
07/25/2025 | 3.4% | UBS | $260 → $180 | Maintains | Neutral | |||
07/25/2025 | 3.4% | Truist Securities | $335 → $180 | Downgrade | Buy → Hold | |||
07/25/2025 | 6.85% | Barclays | $270 → $186 | Maintains | Equal-Weight | |||
07/25/2025 | 20.63% | Cantor Fitzgerald | $312 → $210 | Downgrade | Overweight → Neutral | |||
07/25/2025 | 2.83% | Baird | $373 → $179 | Maintains | Neutral | |||
07/23/2025 | 24.08% | Wells Fargo | $372 → $216 | Maintains | Overweight | |||
07/16/2025 | 92.44% | Truist Securities | $400 → $335 | Maintains | Buy | |||
07/11/2025 | 89.57% | Mizuho | $400 → $330 | Maintains | Outperform | |||
07/10/2025 | 52.8% | Morgan Stanley | $364 → $266 | Downgrade | Overweight → Equal-Weight | |||
06/09/2025 | 99.33% | Barclays | $351 → $347 | Maintains | Equal-Weight | |||
06/09/2025 | 109.1% | Morgan Stanley | → $364 | Initiates | → Overweight | |||
06/02/2025 | 101.63% | Barclays | $362 → $351 | Maintains | Equal-Weight | |||
04/25/2025 | 107.95% | Barclays | $339 → $362 | Maintains | Equal-Weight | |||
04/22/2025 | 137.82% | Bernstein | → $414 | Initiates | → Outperform | |||
04/15/2025 | 115.42% | Baird | $331 → $375 | Downgrade | Outperform → Neutral | |||
04/11/2025 | 129.78% | Truist Securities | $340 → $400 | Maintains | Buy | |||
04/09/2025 | — | Guggenheim | — | Initiates | → Neutral | |||
04/09/2025 | 129.78% | Mizuho | $376 → $400 | Maintains | Outperform | |||
03/05/2025 | 113.69% | Wells Fargo | $295 → $372 | Upgrade | Equal-Weight → Overweight | |||
03/03/2025 | 115.99% | Mizuho | $382 → $376 | Maintains | Outperform | |||
02/19/2025 | 95.31% | Truist Securities | $370 → $340 | Maintains | Buy | |||
02/07/2025 | 94.74% | Barclays | $372 → $339 | Maintains | Equal-Weight | |||
02/07/2025 | 86.7% | UBS | $374 → $325 | Maintains | Neutral | |||
02/06/2025 | 98.18% | Stephens & Co. | $345 → $345 | Reiterates | Equal-Weight → Equal-Weight | |||
01/06/2025 | 112.55% | Truist Securities | $400 → $370 | Maintains | Buy | |||
12/17/2024 | 101.06% | JP Morgan | $378 → $350 | Assumes | Overweight → Neutral | |||
11/04/2024 | 107.95% | Wells Fargo | $360 → $362 | Maintains | Equal-Weight | |||
10/25/2024 | 113.69% | Barclays | $359 → $372 | Maintains | Equal-Weight | |||
10/24/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
10/24/2024 | 90.14% | Baird | $405 → $331 | Maintains | Outperform | |||
10/01/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
09/10/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
08/19/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
08/05/2024 | 106.8% | Wells Fargo | $315 → $360 | Maintains | Equal-Weight | |||
07/29/2024 | 102.78% | Deutsche Bank | $354 → $353 | Maintains | Hold | |||
07/29/2024 | 117.14% | TD Cowen | $351 → $378 | Maintains | Buy | |||
07/25/2024 | 83.82% | Stephens & Co. | $320 → $320 | Reiterates | Equal-Weight → Equal-Weight | |||
07/25/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
07/24/2024 | 101.63% | TD Cowen | $412 → $351 | Maintains | Buy | |||
07/24/2024 | 70.61% | Jefferies | $354 → $297 | Maintains | Hold | |||
07/23/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
07/22/2024 | 80.95% | Wells Fargo | $375 → $315 | Maintains | Equal-Weight | |||
07/15/2024 | 129.78% | Truist Securities | $440 → $400 | Maintains | Buy | |||
07/10/2024 | 126.91% | JP Morgan | $420 → $395 | Maintains | Overweight | |||
05/30/2024 | 141.27% | JP Morgan | $435 → $420 | Maintains | Overweight | |||
05/30/2024 | 132.65% | Baird | → $405 | Initiates | → Outperform | |||
04/30/2024 | 136.67% | TD Cowen | $453 → $412 | Maintains | Buy | |||
04/29/2024 | 115.42% | Wells Fargo | $410 → $375 | Maintains | Equal-Weight | |||
04/25/2024 | 124.03% | Stephens & Co. | $390 → $390 | Reiterates | Equal-Weight → Equal-Weight | |||
04/25/2024 | 147.01% | Barclays | $437 → $430 | Maintains | Equal-Weight | |||
04/15/2024 | 135.52% | Wells Fargo | $440 → $410 | Maintains | Equal-Weight | |||
04/04/2024 | 133.23% | Cantor Fitzgerald | $406 → $406 | Reiterates | Overweight → Overweight | |||
04/01/2024 | 152.18% | B of A Securities | → $439 | Downgrade | Neutral → Underperform | |||
03/28/2024 | 152.18% | B of A Securities | → $439 | Downgrade | Neutral → Underperform | |||
03/20/2024 | 152.76% | Wells Fargo | $420 → $440 | Maintains | Equal-Weight | |||
03/06/2024 | 151.03% | Barclays | → $437 | Initiates | → Equal-Weight | |||
02/20/2024 | 164.25% | Truist Securities | $435 → $460 | Maintains | Buy | |||
02/15/2024 | 141.27% | Wells Fargo | $367 → $420 | Upgrade | Underweight → Equal-Weight | |||
02/09/2024 | 133.23% | Cantor Fitzgerald | $374 → $406 | Maintains | Overweight | |||
12/21/2023 | 118.29% | UBS | $350 → $380 | Maintains | Neutral | |||
11/21/2023 | 114.84% | Cantor Fitzgerald | → $374 | Reiterates | Overweight → Overweight | |||
11/17/2023 | 125.18% | JP Morgan | $367 → $392 | Maintains | Overweight | |||
10/03/2023 | 101.06% | Stephens & Co. | → $350 | Reiterates | Equal-Weight → Equal-Weight | |||
09/14/2023 | 106.23% | Cantor Fitzgerald | → $359 | Reiterates | Overweight → Overweight | |||
07/14/2023 | 109.67% | Morgan Stanley | $365 → $365 | Reiterates | Overweight → Overweight | |||
07/07/2023 | 95.89% | JP Morgan | $348 → $341 | Maintains | Overweight | |||
06/20/2023 | 109.67% | Truist Securities | $380 → $365 | Maintains | Buy | |||
06/20/2023 | 78.08% | UBS | → $310 | Initiates | → Neutral | |||
05/08/2023 | 92.44% | Deutsche Bank | $365 → $335 | Maintains | Hold | |||
05/03/2023 | 100.48% | TD Cowen | $380 → $349 | Maintains | Outperform | |||
05/01/2023 | 109.67% | Deutsche Bank | $356 → $365 | Maintains | Hold | |||
04/28/2023 | 101.06% | Credit Suisse | $347 → $350 | Maintains | Outperform | |||
04/28/2023 | 66.59% | Wells Fargo | $282 → $290 | Maintains | Underweight | |||
04/27/2023 | 101.06% | Stephens & Co. | → $350 | Reiterates | → Equal-Weight | |||
04/21/2023 | 103.35% | Cantor Fitzgerald | → $354 | Initiates | → Overweight | |||
03/21/2023 | 61.99% | Wells Fargo | $307 → $282 | Maintains | Underweight | |||
02/23/2023 | 99.91% | JP Morgan | $360 → $348 | Maintains | Overweight | |||
02/17/2023 | 76.36% | Wells Fargo | $340 → $307 | Maintains | Underweight | |||
02/10/2023 | 118.29% | Truist Securities | $400 → $380 | Maintains | Buy | |||
02/10/2023 | 99.33% | Credit Suisse | $395 → $347 | Maintains | Outperform | |||
02/09/2023 | 115.42% | Stephens & Co. | → $375 | Maintains | Equal-Weight | |||
01/04/2023 | 115.42% | Barclays | $400 → $375 | Maintains | Overweight | |||
01/03/2023 | 95.31% | Wells Fargo | $345 → $340 | Maintains | Underweight | |||
12/13/2022 | 122.89% | B of A Securities | → $388 | Upgrade | Underperform → Neutral | |||
11/01/2022 | 103.93% | Deutsche Bank | $315 → $355 | Maintains | Hold | |||
10/28/2022 | 129.78% | Barclays | $380 → $400 | Maintains | Overweight | |||
10/28/2022 | 141.27% | Truist Securities | $390 → $420 | Maintains | Buy | |||
10/27/2022 | 135.52% | Credit Suisse | $350 → $410 | Maintains | Outperform | |||
10/03/2022 | 106.8% | JP Morgan | → $360 | Initiates | → Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Molina Healthcare (MOH)?
El último precio objetivo de Molina Healthcare (NYSE:MOH) fue comunicado por Cantor Fitzgerald el agosto 26, 2025. La firma de analistas fijó un precio objetivo para $210.00 que espera MOH a rise dentro de 12 meses (un posible 20.63% upside). 35 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Molina Healthcare (MOH)?
La última calificación de analistas para Molina Healthcare (NYSE:MOH) fue proporcionada por Cantor Fitzgerald, y Molina Healthcare reiterado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Molina Healthcare (MOH)?
La última revisión al alza de Molina Healthcare Inc se produjo en marzo 5, 2025, cuando Wells Fargo elevó su precio objetivo a $372. Wells Fargo anteriormente tenía an equal-weight para Molina Healthcare Inc.
¿Cuándo fue la última revisión a la baja de Molina Healthcare (MOH)?
La última revisión a la baja de Molina Healthcare Inc se produjo en julio 25, 2025, cuando Truist Securities cambió su precio objetivo de $335 a $180 para Molina Healthcare Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Molina Healthcare (MOH)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Molina Healthcare, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Molina Healthcare se registró el agosto 26, 2025, por lo que la próxima calificación estará disponible en torno al agosto 26, 2026.
¿Es correcta la calificación de los analistas sobre Molina Healthcare (MOH)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Molina Healthcare (MOH) fue un reiterado con un precio objetivo de $210.00 a $210.00. El precio actual al que cotiza Molina Healthcare (MOH) es de $174.08, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.